Chemical and biological aspects of extracts from medicinal plants with antidiabetic effects

Review of Diabetic Studies

Volumn 13, Issue 2-3, 2016, Pages 96-112

  Gushiken, Lucas F ^a   Beserra, Fernando P ^a   Rozza, Ariane L ^a   Bérgamo, Patrícia L ^a   Bérgamo, Danilo A ^a   Pellizzon, Cláudia H ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antidiabetic substances; Betacell; Diabetic complications; Islet of Langerhans; Medicinal plants; Toxicity; Type 2 diabetes mellitus

Indexed keywords

CAFESTOL; CHLOROGENIC ACID; COUMARIN DERIVATIVE; CRYPTOLEPINE; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; INDOLOQUINOLINE DERIVATIVE; ISOORIENTIN; ISOSTEVIOL; MARSUPSINE; PHENOL DERIVATIVE; PLANT EXTRACT; QUERCETIN; RUTOSIDE; SAPONIN; SESQUITERPENE DERIVATIVE; SILIBININ; STEVIOSIDE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT;

AIZOACEAE; ALBIZIA LEBBECK; ALOE VERA; AMARANTHUS TRICOLOR; ANTIDIABETIC ACTIVITY; APOCYNACEAE; ASTERACEAE; AVOCADO; AZADIRACHTA INDICA; BAUHINIA; BAUHINIA THONINGII; BLACK CUMIN; CAESALPINIA; CAMELLIA SINENSIS; CASSIA FISTULA; CHILIADENUS IPHIONOIDES; CINNAMOMUM CASSIA; COLOCYNTH; DRUG MECHANISM; FICUS RACEMOSA; GYMNEMA SYLVESTRE; JUGLANS REGIA; MEDICINAL PLANT; MOMORDICA CHARANTIA; MORINGA OLEIFERA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPUNTIA; OREGANO; PASSIFLORA NITIDA; PICRALIMA NITIDA; PIPER LONGUM; REVIEW; SOLANACEAE; SONCHUS OLERACEUS; SYZYGIUM CUMINI; TAMARIND; WITHERINGIA SOLANACEA; ZALEYA DECANDRA; ANIMAL; DIABETES MELLITUS; DRUG EFFECTS; HUMAN; PANCREAS;

ANIMALS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; PANCREAS; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 85007442724     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2016.13.96     Document Type: Review

References (108)

1. Desgraz R, Bonal C, Herrera PL. Beta-cell regeneration: the pancreatic intrinsic faculty. Trends Endocrinol Metab 2011. 22(1):34-43.
2. Zhang S, Liu H, Chuang CL, Li X, Au M, Zhang L, Phillips AR, Scott DW, Cooper GJ. The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet beta cells. FASEB J 2014. 28(12):5083-5096.
3. Slack JM. Developmental biology of the pancreas. Development 1995. 121(6):1569-1580.
4. Khavandi K, Amer H, Ibrahim B, Brownrigg J. Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis 2013. 4(5):242-261.
5. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001. 358(9277):221-229.
6. Li WL, Zheng HC, Bukuru J, Kimpe ND. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004. 92(1):1-21.
7. Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2012. 2(11):a007641.
8. Kasuga M. Insulin resistance and pancreatic beta cell failure. J Clin Invest 2006. 116(7):1756-1760.
9. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008. 9(3):193-205.
10. Ezuruike UF, Priet JM. The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J Ethnopharmacol 2014. 155(2):857-924.
11. Daneman D. Type 1 diabetes. Lancet 2006. 367(9513):847-858.
12. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005. 365(9467):1333-1346.
13. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007. 369(9575):1823-1831.
14. Boyle PJ. Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am J Med 2007. 120(9):12-17.
15. Frode TS, Medeiros YS. Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol 2008. 115(2):173-183.
16. Masiello P. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int J Biochem Cell Biol 2006. 38(5-6):873-893.
17. Lenzen S. The mechanisms of alloxan and streptozotocin induced diabetes. Diabetologia 2008. 51(2):216-226.
18. Lenzen S, Munday R. Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its n-methyl derivatives and a comparison with ninhydrin. Biochem Pharmacol 1991. 42(7):1385-1391.
19. Gorus FK, Malaisse WJ, Pipeleers DG. Selective uptake of alloxan by pancreatic beta-cells. Biochem J 1982. 208(2):513-515.
20. Lenzen S, Panten U. Alloxan: history and mechanism of action. Diabetologia 1988. 31(6):337-342.
21. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001. 50(6):537-546.
22. Mythili MD, Vyas R, Akila G, Gunasekaran S. Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech 2004. 63(5):274-281.
23. Pascoe WS, Storlien LH. Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function. Model for study of etiology and pathogenesis of NIDDM. Diabetes 1990. 39(2):226-233.
24. Skovso S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig 2014. 5(4):349-358.
25. Volpato GT, Damasceno DC, Calderon IM, Rudge MV. Revisao de plantas Brasileiras com comprovado efeito hipoglicemiante no controle do diabetes mellitus. Rev Bras Plantas Med 2002. 4(2):35-45.
26. Bisla G, Choudhary S, Chaudhary V. Evaluation of the nutritive and organoleptic values of food products developed by incorporated Catharanthus roseus (Sadabahar) fresh leaves explore their hypoglycemic potential. Sci World J 2014. 2014:304120.
27. Eddouks M, Bidi A, Bouhali BE, Hajji L, Zeggwagh NA. Antidiabetic plants improving insulin sensitivity. J Pharm Pharmacol 2014. 66(9):1197-1214.
28. Huang D, Jiang Y, Chen W, Yao F, Huang G, Suna L. Evaluation of hypoglycemic effects of polyphenols and extracts from Penthorum chinense. J Ethnopharmacol 2015. 163:256-263.
29. Cheng L, Meng X, Lu S, Wang T, Liu Y, Sun G, Sun X. Evaluation of hypoglycemic efficacy of tangningtongluo formula, a traditional Chinese Miao medicine, in two rodent animal models. J Diabetes Res 2014. 2014:745419.
30. Nkambo W, Anyama NG, Onegi B. In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L. Afr Health Sci 2013. 13(4):933-939.
31. Ahmed D, Kumar V, Verma A, Gupta PS, Kumar H, Dhingra V, Mishra V, Sharma M. Antidiabetic, renal/ hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats. BMC Complement Altern Med 2014. 14(1):243-259.
32. Kumar R, Sharma B, Tomar NR, Roy P, Gupta AK, Kumar A. In vivo evaluation of hypoglycemic activity of Aloe spp. and identification of its mode of action on GLUT-4 gene expression in vitro. Appl Biochem Biotechnol 2011. 164(8):1246-1256.
33. Rahmatullah M, Hosain M, Rahman S, Akter M, Rahman F, Rehana F, Munmun M, Kalpana MA. Antihyperglycemic and antinociceptive activity evaluation of methanolic extract of whole plant of Amaranthus Tricolor L. (Amaranthaceae). Afr J Tradit Complement Altern Med 2013. 10(5):408-411.
34. Akhtar N, Khan BA, Majid A, Khan HM, Mahmood T, Gulfishan, Saeed T. Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits. Acta Pol Pharm 2011. 68(6):919-925.
35. Ojezele MO, Abatan OM. Hypoglycaemic and coronary risk index lowering effects of Bauhinia thoningii in alloxan induced diabetic rats. Afr Health Sci 2011. 11(1):85-89.
36. Ueda H, Kawanishi K, Moriyasu M. Effects of ellagic acid and 2-(2,3,6-trihydroxy-4-carboxyphenyl) ellagic acid on sorbitol accumulation in vitro and in vivo. Biol Pharm Bull 2004. 27(10):1584-1587.
37. Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate 1. Endocrinology 2000. 141(3):980-987.
38. Mai TT, Chuyen NV. Anti-hyperglycemic activity of an aqueous extract from flower buds of Cleistocalyx operculatus (Roxb.) Merr and Perry. Biosci Biotechnol Biochem 2007. 71(1):69-76.
39. Zhou G, Myers R, Li Y, Chen Y, Shen X, FenykMelody J, Wu M, Ventre J, Doebber T, Fujii N, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001. 108(8):1167-1174.
40. Vasconcelos CF, Maranhão HM, Batista TM, Carneiro EM, Ferreira F, Costa J, Soares LA, Sa MD, Souza TP, Wanderley AG. Hypoglycaemic activity and molecular mechanisms of Caesalpinia ferrea Martius bark extract on streptozotocin-induced diabetes in Wistar rats. J Ethnopharmacol 2011. 137(3):1533-1541.
41. Al-Attar AM, Zari TA. Influences of crude extract of tea leaves, Camellia sinensis, on streptozotocin diabetic male albino mice. Saudi J Biol Sci 2010. 17(4):295-301.
42. Agnihotri A, Singh V. Effect of Tamarindus indica Linn. and Cassia fistula Linn. stem bark extracts on oxidative stress and diabetic conditions. Acta Pol Pharm 2013. 70(6):1011-1019.
43. Aragao DM, Guarize L, Lanini J, Costa JC, Garcia RM, Scio E. Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats. J Ethnopharmacol 2010. 128(3):629-633.
44. Gorelick J, Kitron A, Pen S, Rosenzweig T, Madar Z. Antidiabetic activity of Chiliadenus iphionoides. J Ethnopharmacol 2011. 137(3):1245-1249.
45. Lu Z, Jia Q, Wang R, Wu X, Wu Y, Huang C, Li Y. Hypoglycemic activities of A-and B-type procyanidin oligomer-rich extracts from different Cinnamon barks. Phytomedicine 2011. 18(4):298-302.
46. Agarwal V, Sharma AK, Upadhyay GS, Gupta R. Hypoglycemic effects of Citrullus Colocynthis roots. Acta Pol Pharm 2012. 69(1):75-79.
47. Gul-e-Rana, Karim S, Khurhsid R, Saeed-ul-Hassan S, Tariq I, Sultana M, Rashid AJ, Shah SH, Murtaza G. Hypoglycemic activity of Ficus racemosa bark in combination with oral hypoglycemic drug in diabetic human. Acta Pol Pharm 2013. 70(6):1045-1049.
48. Kang MH, Lee MS, Choi MK, Min KS, Shibamoto T. Hypoglycemic activity of Gymnema sylvestre extracts on oxidative stress and antioxidant status in diabetic rats. J Agric Food Chem 2012. 60(10):2517-2524.
49. Hosseini S, Huseini HF, Larijani B, Mohammad K, Najmizadeh A, Nourijelyani K, Jamshidi L. The hypoglycemic effect of Juglans regia leaves aqueous extract in diabetic patients: A first human trial. Daru 2014. 22(1):19-23.
50. Gupta R, Mathur M, Bajaj VK, Katariya P, Yadav S, Kamal R, Gupta RS. Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes. J Diabetes 2012. 4(2):164-171.
51. Alimohammadi S, Hobbenaghi R, Javanbakht J, Kheradmand D, Mortezaee R, Tavakoli M, Khadivar F, Akbari H. Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn Pathol 2013. 8(1):137-143.
52. Luo C, Zhang W, Sheng C, Zheng C, Yao J, Miao Z. Chemical composition and antidiabetic activity of Opuntia Milpa Alta extracts. Chem Biodivers 2010. 7(12):2869-2879.
53. Vujicic M, Nikolic I, Kontogianni VG, Saksida T, Charisiadis P, Orescanin-Dusic Z, Blagojevic D, Stosic-Grujicic S, Tzakos AG, Stojanovic I. Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and antiapoptotic activity. Br J Nutr 2015. 113(5):770-782.
54. Montefusco-Pereira CV, Carvalho MJ, Boleti AP, Teixeira LS, Matos HR, Lima ES. Antioxidant, antiinflammatory, and hypoglycemic effects of the leaf extract from Passiflora nitida kunth. Appl Biochem Biotechnol 2013. 170(6):1367-1378.
55. Lima CR, Vasconcelos CF, Costa-Silva JH, Maranhao CA, Costa J, Batista TM, Carneiro EM, Soares LA, Ferreira F, Wanderley AG. Antidiabetic activity of extract from Persea americana Mill. leaf via the activation of protein kinase B (PKB/Akt) in streptozotocin-induced diabetic rats. J Ethnopharmacol 2012. 141(1):517-525.
56. Teugwa CM, Mejiato PC, Zofou D, Tchinda BT, Boyom FF. Antioxidant and antidiabetic profiles of two African medicinal plants: Picralima nitida (Apocynaceae) and Sonchus oleraceus (Asteraceae). BMC Complement Altern Med 2013. 13(1):175-183.
57. Nabi SA, Kasetti RB, Sirasanagandla S, Tilak TK, Kumar MV, Rao CA. Antidiabetic and antihyperlipidemic activity of Piper longum root aqueous extract in STZ induced diabetic rats. BMC Complement Altern Med 2013. 13(1):37-45.
58. El-Sayed MI. Effects of Portulaca oleracea L. seeds in the treatment of type 2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol 2011. 137(1):643-651.
59. Herrera C, GarciaBarrantes PM, Binns F, Vargas M, Poveda L, Badilla S. Hypoglycemic and antihyperglycemic effect of Witheringia solanacea in normal and alloxaninduced hyperglycemic rats. J Ethnopharmacol 2011. 133(2):907-910.
60. Meenakshi P, Bhuvaneshwari R, Rathi MA, Thirumoorthi L, Guravaiah DC, Jiji MJ, Gopalakrishnan VK. Antidiabetic activity of ethanolic extract of Zaleya decandra in alloxan-induced diabetic rats. Appl Biochem Biotechnol 2010. 162(4):1153-1159.
61. Lamba SS, Buch KY, Lewis H, Lamba J. Phytochemicals as potential hypoglycemic agents. Nat Prod Chem 2000. 21:457-496.
62. Koshy AS, Vijayalakshmi NR. Impact of certain flavonoids on lipid profiles potential action of Garcinia cambogia flavonoids. Phyther Res 2001. 15(5):395-400.
63. El-Mawla AM, Mohamed KM, Mostafa AM. Induction of biologically active flavonoids in cell cultures of Morus nigra and testing their hypoglycemic efficacy. Sci Pharm 2011. 79(4):951-961.
64. Hnatyszyn O, Mino J, Ferraro G, Acevedo C. The hypoglycemic effect of Phyllanthus sellowianus fractions in streptozotocin-induced diabetic mice. Phytomedicine 2002. 9(6):556-559.
65. Andrade-Cetto A, Wiedenfeld H. Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 2001. 78(2-3):145-149.
66. Revilla MC, Andrade-Cetto A, Islas S, Wiedenfeld H. Hypoglycemic effect of Equisetum myriochaetum aerial parts on type 2 diabetic patients. J Ethnopharmacol 2002. 81(1):117-120.
67. Kazazis CE, Evangelopoulos AA, Kollas A, Vallianou NG. The therapeutic potential of milk thistle in diabetes. Rev Diabet Stud 2014. 11(2):167-174.
68. Rao AV, Gurfinkel DM. The bioactivity of saponins: triterpenoid and steroidal glycosides. Drug Metabol Drug Interact 2000. 17(1-4):211-235.
69. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 2005. 50(1):24-33.
70. Marukami T, Kishi A, Yoshikawa M. Medicinal flowers. IV. Marigold. (2): Structures of new ionone and sesquiterpene glycosides from Egyptian Calendula officinalis. Chem Pharm Bull (Tokyo) 2001. 49(8):974-978.
71. Venkatesh S, Reddy GD, Reddy BM, Ramesh M, Rao AV. Antihyperglycemic activity of Caralluma attenuata. Fitoterapia 2003. 74(3):274-279.
72. Khan MT, Ather A, Pinto AC, Maciel MA. Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system. Rev Bras Farmacogn 2009. 19:7-13.
73. Soman S, Rauf AA, Indira M, Rajamanickam C. Antioxidant and antiglycative potential of ethyl acetate fraction of Psidium guajava leaf extract in streptozotocin-induced diabetic rats. Plant Foods Hum Nutr 2010. 65(4):386-391.
74. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, et al. Replication of an Association Between the Lymphoid General Autoimmunity Locus. Diabetes 2004. 53:3020-3023.
75. Jeppesen PB, Dyrskog SE, Agger A, Gregersen S, Colombo M, Xiao J, Hermansen K. Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic Goto-Kakizaki rat. Rev Diabet Stud 2006. 3(4):189-199.
76. Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K. Isosteviol increases insulin sensitivity and changes gene expression of key insulin regulatory genes and transcription factors in islets of the diabetic KKAy mouse. Diabetes Obes Metab 2008. 10(10):939-949.
77. Mellbye FB, Jeppesen PB, Hermansen K, Gregersen S. Cafestol, a Bioactive Substance in Coffee, Stimulates Insulin Secretion and Increases Glucose Uptake in Muscle Cells: Studies in Vitro. J Nat Prod 2015. 78(10):2447-2451.
78. Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. Biomed Res Int 2013. 2013:963248.
79. Patel DK, Kumar R, Laloo D, Hemalatha S. Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed 2012. 2(5):411-420.
80. Kubo H, Inoue M, Kamei J, Higashiyama K. Hypoglycemic effects of multiflorine derivatives in normal mice. Biol Pharm Bull 2006. 29(10):2046-2050.
81. Nistico L, Buzzetti R, Pritchard LE, Auwera BV, Giovannini C, Bosi E, Teresa M, Larrad M, Rios MS, Chow CC, et al. The CTLA-4 gene region of chromosome 2q33 is linked to and associated with, type 1 diabetes. Hum Mol Genet 1996. 5(7):1075-1080.
82. Konturek PC, Brzozowski T, Burnat G, Szlachcic A, Koziel J, Kwiecien S, Konturek SJ, Harsch IA. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats. J Physiol Pharmacol 2010. 61(4):429-436.
83. Hurst WJ, Krake SH, Bergmeier SC, Payne MJ, Miller KB, Stuart DA. Impact of fermentation, drying, roasting and Dutch processing on flavan-3-ol stereochemistry in cacao beans and cocoa ingredients. Chem Cent J 2011. 5:53-62.
84. Jiang CS, Liang L, Guo Y. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacol Sin 2012. 33(10):1217-1245.
85. Isik F, Akbay TT, Yarat A, Genc Z, Pisiriciler R, CaliskanAk E, Cetinel S, Altıntas A, Sener G. Protective effects of black cumin (Nigella sativa) oil on TNBSinduced experimental colitis in rats. Dig Dis Sci 2011. 56(3):721-730.
86. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003. 200(4):500-503.
87. Futagami A, Ishizaki M, Fukuda Y, Kawana S, Yamanaka N. Wound Healing Involves Induction of Cyclooxygenase-2 Expression in Rat Skin. Lab Invest 2002. 82(11):1503-1513.
88. Fikru A, Makonnen E, Eguale T, Debella A, Mekonnen GA. Evaluation of in vivo wound healing activity of methanol extract of Achyranthes aspera L. J Ethnopharmacol 2012. 143(2):469-474.
89. Singh R, Kaur N, Kishore L, Gupta GK. Management of diabetic complications: a chemical constituents based approach. J Ethnopharmacol 2013. 150(1):51-70.
90. Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A. Medicinal plants with potential antidiabetic activity -a review of ten years of herbal medicine research (1990-2000). Int J Diabetes Metab 2006. 14:1-25.
91. Sefi M, Fetoui H, Makni M, Zeghal N. Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats. Food Chem Toxicol 2010. 48(7):1986-1993.
92. Czinner E, Hagymasi K, Blazovics A, Kery A, Szoke E, Lemberkovics E. In vitro antioxidant properties of Helichrysum arenarium (L.) Moench. J Ethnopharmacol 2000. 73(3):437-443.
93. Fang XK, Gao J, Zhu DN. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci 2008. 82(11-12):615-622.
94. Afolayan AJ, Sunmonu TO. Artemisia afra Jacq. ameliorates oxidative stress in the pancreas of streptozotocininduced diabetic Wistar rats. Biosci Biotechnol Biochem 2011. 75(11):2083-2086.
95. Eliza J, Daisy P, Ignacimuthu S, Duraipandiyan V. Normoglycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.) Sm. in streptozotocin-induced diabetic rats. Chem Biol Interact 2009. 179(2-3):329-334.
96. Thome RG, Santos HB, Santos FV, Oliveira RJ, Camargos LF, Pereira MN, Longatti TR, Souto CM, Franco CS, Schüffner RO, et al. Evaluation of healing wound and genotoxicity potentials from extracts hydroalcoholic of Plantago major and Siparuna guianensis. Exp Biol Med (Maywood) 2012. 237(12):1379-1386.
97. Asai M, Iwata N, Yoshikawa A, Aizaki Y, Ishiura S, Saido TC, Maruyama K. Berberine alters the processing of Alzheimer’s amyloid precursor protein to decrease Abeta secretion. Biochem Biophys Res Commun 2007. 352(2):498-502.
98. Yankuzo H, Ahmed QU, Santosa RI, Akter SF, Talib NA. Beneficial effect of the leaves of Murraya koenigii (Linn.) Spreng (Rutaceae) on diabetes-induced renal damage in vivo. J Ethnopharmacol 2011. 135(1):88-94.
99. Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet 2001. 358(9283):739-746.
100. Perez-Fernandez R, Fresno N, Goya P, Elguero J, Menendez-Taboada L, Garcia-Granda S, Marco C. Structure and thermodynamical properties of metformin salicylate. Cryst Growth Des 2013. 13(4):1780-1785.
101. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995. 333(9):541-549.
102. Alhemiarya NA. Derivative spectrophotometric and HPLC-validated methods for simultaneous determination of metformin and glibenclamide in combined dosage form. Orient J Chem 2014. 30(4):1507-1516.
103. Nagashima K, Takahashi A, Ikeda H, Hamasaki A, Kuwamura N, Yamada Y, Seino Y. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmacological properties and tissue selectivity. Diabetes Res Clin Pract 2004. 66(1):75-78.
104. Gupta V. Glucagon-like peptide-1 analogues: an overview. Indian J Endocrinol Metab 2013. 17(3):413-421.
105. Dharmalingam M, Sriram U, Baruah MP. Liraglutide: a review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus. Indian J Endocrinol Metab 2011. 15(1):9-17.
106. Wang Y, Xu N, Ye C, Liu L, Shi Z, Wu J. Reconstruction and in silico analysis of an Actinoplanes sp. SE50/110 genome-scale metabolic model for acarbose production. Front Microbiol 2015. 6:632.
107. McCarty MF, DiNicolantonio JJ. Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1. Open Heart 2015. 2(1):e000205.
108. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul AD. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007. 40(3):163-173.